Basic Information
Basic information for AL078590.2-201-16aa-1
Peptide Name AL078590.2-201-16aa-1
Genome Position chr6:134540252-134540299[-]
Species Human
Peptide Sequence MKQEPPWDSSDESQFQ
Peptide Length 16
Unique No (AL078590.2-214-16aa,AL078590.2-215-16aa-1,AL078590.2-212-16aa,AL078590.2-204-16aa-1,AL078590.2-211-16aa,AL078590.2-210-16aa-1)
Grand Average of Hydropathicity -1.8875
Relative Molecular Mass 2209.25
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000232310;AL078590.2
Transcript ID/Name ENST00000650393;AL078590.2-201
Transcript Length 2643
Coding Ability 0.3746
DNA Sequence Corresponding to Peptide ATGAAGCAGGAGCCACCCTGGGATTCCTCAGATGAAAGCCAATTTCAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :